36E79726R0004_1.docx
DOCX document 17 KB Posted
- Attached to
- 6505--Buprenorphine Pre-solicitation notice Federal contract opportunity
- Solicitation number
- 36E79726R0004
About this file
This document is a pre-solicitation notice for a federal contract opportunity for Buprenorphine HCL/Naloxone HCL Tablets. The VA National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79726R0004 for an unrestricted procurement spanning multiple federal agencies, including the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS).
The procurement will award one contract for a one-year base period with four additional one-year option periods. The estimated annual requirements include 171,239 bottles of Buprenorphine HCL 2mg/Naloxone HCL 0.5mg Tablets and 251,144 bottles of Buprenorphine HCL 8mg/Naloxone HCL 2mg Tablets, both in 30-tablet sublingual formats. The solicitation will be electronically issued in commercial item format on or about 01/05/2026, with a tentative closing date of 01/19/2026. Contract items will be distributed through VA and DOD Pharmaceutical Prime Vendor Programs. Offerors must provide the exact drug name as it appears on the label and include a unique NDC number, with glass bottles explicitly not acceptable.
View the file
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
SUBJECT*
Buprenorphine Pre-solicitation notice
GENERAL INFORMATION
| CONTRACTING OFFICE’S ZIP CODE* |
| 60141 |
| SOLICITATION NUMBER* |
| 36E79726R0004 |
| RESPONSE DATE/TIME/ZONE |
| 01-19-2026 2:30pm CENTRAL TIME, CHICAGO, USA |
| ARCHIVE |
| 99 DAYS AFTER THE RESPONSE DATE |
SET-ASIDE
| PRODUCT SERVICE CODE* |
| 6505 |
| NAICS CODE* |
| 325412 |
PLACE OF PERFORMANCE
POSTAL CODE
COUNTRY
CONTACT INFORMATION
CONTRACTING OFFICE ADDRESS
POINT OF CONTACT*
Amber Zavala Amber.Zavala@va.gov amber.zavala@va.gov
(708) 786-5245
ADDITIONAL INFORMATION
AGENCY’S URL
URL DESCRIPTION
AGENCY CONTACT’S EMAIL ADDRESS
EMAIL DESCRIPTION
Presolicitation Notice Presolicitation Notice
DESCRIPTION
| *=Required Field |
| Presolicitation Notice |
Presolicitation Notice
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79726R0004 for an unrestricted procurement for Buprenorphine HCL/Nalaxone HCL Tablets, for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA’s and DOD’s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number. Glass bottles are not acceptable. Solicitation # 36E79726R0004 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about 01/05/2026 with a tentative closing date of 01/19/2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Amber Zavala. Questions can be e-mailed to: amber.zavala@va.gov.
The estimated annual requirements are as follows:
Description Size Estimated Annual Requirements (Bottle)
BuprenorphineHCL 2mg/Naloxone HCL 0.5mg Tab, Sublingual 30 171,239 BuprenorphineHCL 8mg/Naloxone HCL 2mg Tab, Sublingual 30 251,144
File details come from the government source that posted it. Updated .